ERDEMOĞLU, E. Et Al. 2009. RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.19, no.3 , 375-379.

ERDEMOĞLU, E., GÜNEY, M., Take, G., Giray, S. G., & Mungan, T., (2009). RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.19, no.3, 375-379.

ERDEMOĞLU, Evrim Et Al. "RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia," INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.19, no.3, 375-379, 2009

ERDEMOĞLU, Evrim Et Al. "RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.19, no.3, pp.375-379, 2009

ERDEMOĞLU, E. Et Al. (2009) . "RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.19, no.3, pp.375-379.

@article{article, author={Evrim ERDEMOĞLU Et Al. }, title={RAD001 (Everolimus) Can Prevent Tamoxifen-Related Endometrial and Stromal Hyperplasia}, journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER}, year=2009, pages={375-379} }